Global Legalized Cannabis Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Legalized Cannabis Market Research Report 2024
Though cannabis is popular across the globe, it is an illegally utilized drug as its use for various purposes is banned by myriad governments worldwide. The product is referred by names such as marijuana and hemp. In fact, hemp is used for psychological disorders as it has non-psychotic effects on the patients. Marijuana is used for medical or therapeutic purpose as well as recreational use.
According to Mr Accuracy reports’s new survey, global Legalized Cannabis market is projected to reach US$ 39400 million in 2034, increasing from US$ 19910 million in 2024, with the CAGR of 9.8% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Legalized Cannabis market research.
Key manufacturers engaged in the Legalized Cannabis industry include Dixie Elixirs, Cronos Group, Canopy Growth, Aurora Cannabis, ABcann Medicinals, Aphria, Maricann Group and ABcann Medicinals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Legalized Cannabis were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Legalized Cannabis market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Legalized Cannabis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Dixie Elixirs
Cronos Group
Canopy Growth
Aurora Cannabis
ABcann Medicinals
Aphria
Maricann Group
ABcann Medicinals
Segment by Type
Cannabis Herb
Cannabis Resin
Other
Entertainment Venue
Medical Institutions
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Legalized Cannabis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Legalized Cannabis market is projected to reach US$ 39400 million in 2034, increasing from US$ 19910 million in 2024, with the CAGR of 9.8% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Legalized Cannabis market research.
Key manufacturers engaged in the Legalized Cannabis industry include Dixie Elixirs, Cronos Group, Canopy Growth, Aurora Cannabis, ABcann Medicinals, Aphria, Maricann Group and ABcann Medicinals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Legalized Cannabis were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Legalized Cannabis market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Legalized Cannabis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Dixie Elixirs
Cronos Group
Canopy Growth
Aurora Cannabis
ABcann Medicinals
Aphria
Maricann Group
ABcann Medicinals
Segment by Type
Cannabis Herb
Cannabis Resin
Other
Segment by Application
Entertainment Venue
Medical Institutions
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Legalized Cannabis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source